Addition of rapid-acting insulin to basal insulin therapy in type 2 diabetes: indications and modalities (original) (raw)

Basal-bolus insulin therapy in Type 1 diabetes: comparative study of pre-meal administration of a fixed mixture of insulin lispro (50%) and neutral protamine lispro (50%) with human soluble insulin

Vipin Arora

Diabetic Medicine, 2002

View PDFchevron_right

A Stepwise Approach to Insulin Therapy in Patients with Type 2 Diabetes Mellitus and Basal Insulin Treatment Failure

Robert Tanenberg

Endocrine Practice, 2011

View PDFchevron_right

Intensification of Insulin Therapy for Type 2 Diabetic Patients in Primary Care: Basal-Bolus Regimen Versus Premix Insulin Analogs: When and for whom?

I. Raz

Diabetes Care, 2013

View PDFchevron_right

Multiple mealtime administration of biphasic insulin aspart 30 versus traditional basal-bolus human insulin treatment in patients with type 1 diabetes

Torsten Lauritzen

Diabetes, Obesity and Metabolism, 2006

View PDFchevron_right

Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes

Melanie Davies

New England Journal …, 2007

View PDFchevron_right

Basal insulin or premix analogue therapy in type 2 diabetes patients

Philip Raskin

European Journal of Internal Medicine, 2007

View PDFchevron_right

The Effect of Food Intake on the Pharmacokinetics of Oral Basal Insulin: A Randomised Crossover Trial in Healthy Male Subjects

Karsten Wassermann

Clinical Pharmacokinetics

View PDFchevron_right

Insulin Strategies for Type 2 Diabetes Mellitus

eva vivian

Annals of Pharmacotherapy, 2004

View PDFchevron_right

Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with Type 1 diabetes

H. Chase

Diabetic Medicine, 2002

View PDFchevron_right

Comparison of thrice daily 'high' vs. 'medium' premixed insulin aspart with respect to evening and overnight glycaemic control in patients with type 2 diabetes

Anders Lindholm, N. Ejskjaer

Diabetes, Obesity and Metabolism, 2003

View PDFchevron_right

A New-Generation Ultra-Long-Acting Basal Insulin With a Bolus Boost Compared With Insulin Glargine in Insulin-Naive People With Type 2 Diabetes: A randomized, controlled trial

Jaime Davidson

Diabetes Care, 2011

View PDFchevron_right

Benefits of timely basal insulin control in patients with type 2 diabetes

Dragana Lovre

Journal of Diabetes and its Complications, 2015

View PDFchevron_right

Stepwise intensification of insulin therapy in Type 2 diabetes management-exploring the concept of the basal-plus approach in clinical practice

David Owens

Diabetic Medicine, 2013

View PDFchevron_right

Comparison of glycemic variability between basal-bolus and premixed insulin therapy

Satoru Yamada

Journal of Diabetes Mellitus, 2013

View PDFchevron_right

Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: A multinational, 24-week, randomized, open-label, parallel-group comparison

Paul Beisswenger, Zvonko Milicevic

Clinical Therapeutics, 2007

View PDFchevron_right

Safety of basal-bolus versus premixed insulin intensification regimens in the management of type 2 diabetes mellitus: A narrative review of a 14-year experience

Noordin Othman

Journal of Taibah University Medical Sciences, 2015

View PDFchevron_right

Introduction to basal insulin therapy: clinical management of diabetes

Jasmine Gonzalvo

The American journal of managed care, 2018

View PDFchevron_right

Intensifying Treatment of Type 2 Diabetes Mellitus: Adding Insulin

kyle peters

Pharmacotherapy, 2011

View PDFchevron_right

Basal-Bolus Regimen With Insulin Analogues Versus Human Insulin in Medical Patients with type 2 Diabetes: A Randomized Controlled Trial in Latin America

Shirley Alsina

Endocrine Practice, 2015

View PDFchevron_right

In Reply: Starting insulin therapy

Andrei Brateanu

Cleveland Clinic journal of medicine, 2015

View PDFchevron_right

The A1chieve study: a 60 000-person, global, prospective, observational study of basal, meal-time, and biphasic insulin analogs in daily clinical practice

Siddharth shah

Diabetes Research and Clinical Practice, 2010

View PDFchevron_right

Different Insulin Initiation Regimens in Patients with Type 2 Diabetes - A Review Article

Khin Thida

International Journal of Diabetes and Clinical Research, 2018

View PDFchevron_right

Safety and efficacy of basal bolus and premixed insulin intensification regimes in the management of type 2 diabetes mellitus : A 13 year narrative review of literature

Noordin Othman

2014

View PDFchevron_right

Comparative efficacy and safety of basal insulins: A review

hernando vargas-uricoechea

Diabetes & Metabolic Syndrome: Clinical Research & Reviews

View PDFchevron_right

Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes

Jean-françois Yale

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2018

View PDFchevron_right

A Review of New Ultra-long-Acting Basal Insulin: Insulin Glargine 300 Unit

juna paw

View PDFchevron_right

Evidence-based clinical use of insulin premixtures

Marcos A Tambascia

Diabetology & Metabolic Syndrome, 2013

View PDFchevron_right

Basal Insulin Therapy in Type 2 Diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin

Glen Park

Diabetes Care, 2001

View PDFchevron_right

Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents: Basal or prandial insulin? The APOLLO trial and beyond

Wolfgang Landgraf

Diabetes Care, 2009

View PDFchevron_right

Pharmacokinetics and Pharmacodynamics of Therapeutic Doses of Basal Insulins NPH, Glargine, and Detemir After 1 Week of Daily Administration at Bedtime in Type 2 Diabetic Subjects

Paola Lucidi

Diabetes Care, 2011

View PDFchevron_right

Current State and Principles of Basal Insulin Therapy in Type 2 Diabetes

hernando vargas-uricoechea

Journal of Clinical Medicine Research, 2022

View PDFchevron_right

Analysis of Guidelines for Basal-Bolus Insulin Dosing: Basal Insulin, Correction Factor, and Carbohydrate-to-Insulin Ratio

Dennis Steed

Endocrine Practice, 2008

View PDFchevron_right